Probiotics for Diaper Dermatitis
PROBIOTICS FOR TREATING DIAPER DERMATITIS IN CHILDREN - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL
University Maribor
42 participants
Aug 14, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is: Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years? Researchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups. Participants will: * receive 6 droplets daily of probiotic or placebo for 3 weeks and * observe and record improvement of diaper rash symptoms each day using a diary.
Eligibility
Inclusion Criteria2
- presence of diaper dermatitis
- age less than two years
Exclusion Criteria5
- previous use of probiotics
- age more than two years
- an acute bacterial infection
- chronic disease
- local use of antibiotics in the anogenital region
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Multistrain Probiotic OMNiBiOTiC® Panda containing: Bifidobacterium bifidum W23 Bifidobacterium lactis W51 Bifidobacterium lactis W52 Lactococcus lactis W58 and sunflower oil
Placebo containing sunflower oil and maltodextrin
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06755307